Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 31% ± 11% | |
peripheral blood | 14 studies | 28% ± 7% | |
intestine | 10 studies | 31% ± 11% | |
kidney | 8 studies | 29% ± 7% | |
liver | 7 studies | 28% ± 16% | |
brain | 7 studies | 26% ± 4% | |
bone marrow | 6 studies | 28% ± 11% | |
pancreas | 5 studies | 48% ± 20% | |
eye | 5 studies | 20% ± 5% | |
lymph node | 5 studies | 28% ± 22% | |
placenta | 4 studies | 40% ± 16% | |
uterus | 4 studies | 51% ± 10% | |
prostate | 4 studies | 22% ± 6% | |
breast | 4 studies | 31% ± 3% | |
adrenal gland | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6992.54 | 459 / 459 | 100% | 147.33 | 1118 / 1118 |
esophagus | 100% | 6253.29 | 1445 / 1445 | 100% | 120.33 | 183 / 183 |
intestine | 100% | 5692.28 | 966 / 966 | 100% | 102.25 | 527 / 527 |
lung | 100% | 6873.10 | 578 / 578 | 100% | 146.96 | 1155 / 1155 |
ovary | 100% | 7199.56 | 180 / 180 | 100% | 105.85 | 430 / 430 |
pancreas | 100% | 12222.61 | 328 / 328 | 100% | 93.67 | 178 / 178 |
stomach | 100% | 5155.22 | 359 / 359 | 100% | 104.74 | 285 / 286 |
prostate | 100% | 6245.98 | 244 / 245 | 100% | 151.82 | 502 / 502 |
uterus | 100% | 8254.11 | 170 / 170 | 100% | 103.28 | 457 / 459 |
liver | 100% | 5525.90 | 225 / 226 | 100% | 82.66 | 406 / 406 |
thymus | 100% | 6359.64 | 652 / 653 | 100% | 117.75 | 603 / 605 |
bladder | 100% | 4589.57 | 21 / 21 | 99% | 97.52 | 501 / 504 |
brain | 99% | 3262.86 | 2606 / 2642 | 100% | 84.59 | 704 / 705 |
skin | 100% | 10447.11 | 1806 / 1809 | 98% | 112.99 | 463 / 472 |
kidney | 100% | 4882.97 | 89 / 89 | 97% | 83.30 | 872 / 901 |
adrenal gland | 100% | 7374.16 | 258 / 258 | 93% | 56.81 | 213 / 230 |
adipose | 100% | 6499.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.56 | 29 / 29 |
spleen | 100% | 5898.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 103.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.62 | 1 / 1 |
blood vessel | 100% | 6063.99 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3559.99 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 7036.57 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 4846.50 | 768 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 35.07 | 64 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006614 | Biological process | SRP-dependent cotranslational protein targeting to membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | SSR3 |
Protein name | Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma) Translocon-associated protein subunit gamma (Signal sequence receptor subunit gamma) |
Synonyms | TRAPG |
Description | FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. . FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. . |
Accessions | Q9UNL2 ENST00000476217.5 ENST00000496050.1 C9JA28 C9J365 ENST00000463503.5 ENST00000265044.7 [Q9UNL2-1] ENST00000467789.5 [Q9UNL2-2] |